Research and Markets

16 fans

Sharing Options

Contact Information

Laura Wood
Guinness Enterprise Centre
Dublin,
+353-1-415-1258

* Your First Name:
* Your Last Name:
* Subject:

Share on Google+

Press Release Spread

Dublin, Dublin, Ireland

Obsessive-Compulsive Disorder - Pipeline Review, H2 2011 Includes Coverage of Products Based On Various Stages of Development

Dec 06, 2011 / (http://www.myprgenie.com) --

Dublin - Research and Markets(http://www.researchandmarkets.com/research/9ad41e/obsessivecompulsi) has announced the addition of Global Markets Direct's new report "Obsessive-Compulsive Disorder - Pipeline Review, H2 2011" to their offering.

Global Markets Direct's, 'Obsessive-Compulsive Disorder - Pipeline Review, H2 2011', provides an overview of the Obsessive-Compulsive Disorder therapeutic pipeline. This report provides information on the therapeutic development for Obsessive-Compulsive Disorder, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Obsessive-Compulsive Disorder. 'Obsessive-Compulsive Disorder - Pipeline Review, H2 2011' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Obsessive-Compulsive Disorder.
- A review of the Obsessive-Compulsive Disorder products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Obsessive-Compulsive Disorder pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Obsessive-Compulsive Disorder.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Obsessive-Compulsive Disorder pipeline depth and focus of Obsessive-Compulsive Disorder therapeutics.

For more information visit http://www.researchandmarkets.com/research/9ad41e/obsessivecompulsi


Contact: Laura Wood, Senior Manager, , U.S. Fax: 646-607-1907 ,

Category: Health
Word Count:0
Tags: molecule type, disorder pipeline, global markets, disorder products, 2011, counter strategies, H, universities research institutes, global, plan mergers, therapeutic, product portfolio, Obsessive, disorder, pipeline, company university sites, press releases, disorder therapeutics, review, information sourced, 2, company, disorder pipeline depth, project, market, report obsessive, understanding obsessive, player, information, party sources, development, product, pipeline projects, product description mechanism, stage pipeline products
Weblinks: http://www.researchandmarkets.com/research/9ad41e/obsessivecompulsi

Research and Markets

We are the world's leading source for market research and market data, and we hold over 700,000 major research publications from leading publishers, consultants and analysts worldwide. We can provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. We are a one-stop shop for market research reports and industry newsletters from specialist research firms and niche market analysts, and we have clients in over 100 cities worldwide.



Sort by: Newest Oldest
Comments

Add a Comment:

characters left
©2007-2014 MyPRGenie, Inc
Disclaimer